Open AccessValue of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
Author(s) -
Hongyan Li,
Xiaomin Chen,
Yajing Zhang,
Kun Wang,
Zairong Gao
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s293005
Subject(s) - medicine , thyroid cancer , thyroglobulin , nuclear medicine , population , receiver operating characteristic , thyroid , environmental health
To evaluate the diagnostic performance of 18 F-FDG PET/MR in detecting recurrent or metastatic disease in patients with differentiated thyroid cancer (DTC) who have increased thyroglobulin (Tg) levels but a negative 131 I whole-body scan (WBS). The relationship between 18 F-FDG PET/MR and serum Tg levels was explored. We also evaluated the therapeutic impact of PET/MR on patient clinical management.